open access

Vol 87, No 11 (2016)
REVIEW PAPERS Gynecology
Published online: 2016-11-30
Get Citation

Thromboprophylaxis in women undergoing gynecological surgery or assisted reproductive techniques: new advances and challenges

Magdalena Maria Piróg, Robert Jach, Anetta Undas
DOI: 10.5603/GP.2016.0086
·
Pubmed: 27958637
·
Ginekol Pol 2016;87(11):773-779.

open access

Vol 87, No 11 (2016)
REVIEW PAPERS Gynecology
Published online: 2016-11-30

Abstract

Venous thromboembolism (VTE) affects 0.1–0.3% people each year. The risk of VTE following gynecological surgery and invasive procedures is well established and presents one of the major challenges in gynecological practice. Moreover, commonly use assisted reproductive techniques (ART) are reported to increase the risk of VTE. Despite continued efforts to reduce its incidence, postoperative VTE remains the second most common perioperative complication and the third most common cause of mortality.
Several practice guidelines have been developed regarding prophylaxis and treatment of VTE. However, there is a large inconsistency between the recommendations and the medical practice in various centers. Moreover, prophylaxis in gynecological patients and women undergoing ART should be chosen individually for the patient, taking into account the possible risk factors for VTE and perioperative bleeding complications. Until recently, the percentage of women, who have not received anticoagulant prophylaxis or administrated it inadequately may reach 50%.
This paper presents the current recommendations regarding thromboprophylaxis in women undergoing gynecological
surgery or assisted reproductive techniques and addresses challenging practical issues in this field.

Abstract

Venous thromboembolism (VTE) affects 0.1–0.3% people each year. The risk of VTE following gynecological surgery and invasive procedures is well established and presents one of the major challenges in gynecological practice. Moreover, commonly use assisted reproductive techniques (ART) are reported to increase the risk of VTE. Despite continued efforts to reduce its incidence, postoperative VTE remains the second most common perioperative complication and the third most common cause of mortality.
Several practice guidelines have been developed regarding prophylaxis and treatment of VTE. However, there is a large inconsistency between the recommendations and the medical practice in various centers. Moreover, prophylaxis in gynecological patients and women undergoing ART should be chosen individually for the patient, taking into account the possible risk factors for VTE and perioperative bleeding complications. Until recently, the percentage of women, who have not received anticoagulant prophylaxis or administrated it inadequately may reach 50%.
This paper presents the current recommendations regarding thromboprophylaxis in women undergoing gynecological
surgery or assisted reproductive techniques and addresses challenging practical issues in this field.

Get Citation

Keywords

thromboprophylaxis; venous thromboembolism; hysterectomy; ovarian cancer; assisted reproductive techiques

About this article
Title

Thromboprophylaxis in women undergoing gynecological surgery or assisted reproductive techniques: new advances and challenges

Journal

Ginekologia Polska

Issue

Vol 87, No 11 (2016)

Pages

773-779

Published online

2016-11-30

DOI

10.5603/GP.2016.0086

Pubmed

27958637

Bibliographic record

Ginekol Pol 2016;87(11):773-779.

Keywords

thromboprophylaxis
venous thromboembolism
hysterectomy
ovarian cancer
assisted reproductive techiques

Authors

Magdalena Maria Piróg
Robert Jach
Anetta Undas

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl